![Medical Research Background](https://robbinsllp.com/wp-content/uploads/2022/04/medical-research-background-300x200.jpg)
Investigation of Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc. Misstated the Financial Impact of its Drug LUPKYNIS A shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Aurinia
Aurinia Pharmaceuticals Inc. Misstated the Financial Impact of its Drug LUPKYNIS A shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Aurinia
Li-Cycle Holdings Corp. (LICY) f/k/a Peridot Acquisition Corp. (PDAC) Misrepresented its Business Prospects to Investors A shareholder filed a class action on behalf of all persons and entities that purchased
Lilium N.V. (LILM) f/k/a Qell Acquisition Corp. (QELL) Misled the Investing Public Regarding its Ability to Timely Launch the Lilium Jet A shareholder filed a class action on behalf
Aurinia Pharmaceuticals Inc. Misstated the Financial Impact of its Drug LUPKYNIS A shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Aurinia
Stronghold Digital Mining, Inc. Filed a False and Misleading Prospectus in Support of its IPO A shareholder filed a class action on behalf of all persons and entities that purchased
Volta Inc. (VLTA) Had Material Weaknesses in Internal Controls Leading to a Material Error in its Financial Results A shareholder filed a class action on behalf of persons and
Homology Medicines, Inc. (FIXX) Misled the Investing Public Regarding its Lead Drug Candidate HMI-102 A shareholder filed a class action on behalf of persons and entities that purchased or otherwise
Elon Musk Harmed Twitter (TWTR) Investors by Failing to Disclose His Purchase of Twitter Shares According to the complaint, beginning in January 2022, Elon Musk started to acquire shares of
Affirm Holdings, Inc. (AFRM) Tweeted Misleading Financial Results A shareholder filed a class action on behalf of investors who purchased or otherwise acquired Affirm Holdings, Inc. (NASDAQ: AFRM) on February
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.